MaxCyte, Inc. Expense Breakdown
No Expense Breakdown for MXCT on this site yet.
- 2026-06-30: Cell Engineering Technology $1.68M.
- 2025-06-30: Cell Engineering Technology $1.52M.
Source checked: the stored Expense Breakdown page for MXCT.
Expenses by product
Cost of sales: each quarter (3 month)
| Quarter end | Cell Engineering Technology |
|---|
| 2026-06-30 | $1.68M |
|---|
| 2025-06-30 | $1.52M |
|---|
Depreciation, Depletion and Amortization, Nonproduction: each quarter (3 month)
| Quarter end | Cell Engineering Technology |
|---|
| 2026-06-30 | $953.00K |
|---|
| 2025-06-30 | $1.08M |
|---|
General and Administrative Expense: each quarter (3 month)
| Quarter end | Cell Engineering Technology |
|---|
| 2026-06-30 | $6.55M |
|---|
| 2025-06-30 | $5.80M |
|---|
Operating expenses: each quarter (3 month)
| Quarter end | Cell Engineering Technology |
|---|
| 2026-06-30 | $15.83M |
|---|
| 2025-06-30 | $21.21M |
|---|
Research and development: each quarter (3 month)
| Quarter end | Cell Engineering Technology |
|---|
| 2026-06-30 | $4.06M |
|---|
| 2025-06-30 | $5.67M |
|---|
Selling and Marketing Expense: each quarter (3 month)
| Quarter end | Cell Engineering Technology |
|---|
| 2026-06-30 | $3.11M |
|---|
| 2025-06-30 | $5.15M |
|---|
Share-based Payment Arrangement, Expense: each quarter (3 month)
| Quarter end | Cell Engineering Technology |
|---|
| 2026-06-30 | $1.16M |
|---|
| 2025-06-30 | $3.51M |
|---|